Protea Biosciences Group Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research, and diagnostic applications. Its products include functionalized pipette tips and plates, gel protein separation and recovery, protein sample preparation, amplus HPLC columns and mass spectrometry standards, among others. Proteas services include bioanalytical services and mass spec imaging services. The companys bioanalytical services include biomarker discovery, advanced proteomics and protein, biotherapeutic characterization and peptide quantitation, among others. It also provides label free imaging, translational, and drug and metabolite distribution. The company serves pharmaceutical, clinical, academic and industrial research. Protea is headquartered in Morgantown, West Virginia, the US.

Protea Biosciences Group Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 5
List of Figures 5
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Protea Biosciences Group Inc, Medical Devices Deals, 2012 to YTD 2018 10
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Protea Biosciences Enters into Co-Marketing Agreement with Proteos 13
Protea Biosciences Enters into Agreement with Agilent Technologies 14
Protea Biosciences Enters Into Research Agreement With Virginia Commonwealth University For Molecular Imaging Techniques 15
Waters Enters Into Co-Marketing Agreement With Protea Biosciences Group For LASEI DP-1000 16
Protea Biosciences Group Enters Into Co-Development Agreement With Oak Ridge National Lab 17
Licensing Agreements 18
Protea Biosciences Enters into License Agreement with George Washington University 18
Equity Offering 19
Protea Biosciences Files Registration Statement to Raise up to USD17.3 Million in Public Offering of Shares 19
Protea Biosciences Group Raises USD0.6 Million in Private Placement 20
Protea Biosciences Raises USD0.98 Million in Public Offering of Units 21
Protea Biosciences Raises USD2.53 Million in Public Offering of Units 22
Protea Biosciences Group Completes Private Placement Of Shares For US$0.7 Million 23
Protea Biosciences Completes Private Placement Of Shares For US$0.5 Million 24
Debt Offering 25
Protea Biosciences Raises USD0.1 Million in Private Placement of Debentures 25
Protea Biosciences Raises USD1.61 Million in Private Placement of Debentures 26
Protea Biosciences Raises USD2 Million in Private Placement of Debentures 27
Protea Biosciences Group Completes Private Placement Of Debt Securities For US$0.3 Million 28
Asset Transactions 29
Purdue University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 29
Princeton University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 30
Acquisition 31
Protea Biosciences to Acquire vivoPharm for USD11.2 Million 31
AzurRx BioPharma Acquires ProteaBio Europe for USD7 Million 33
Protea Biosciences Group Inc - Key Competitors 34
Protea Biosciences Group Inc - Key Employees 35
Protea Biosciences Group Inc - Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
Financial Announcements 37
Apr 18, 2017: Protea Announces 2016 Year End Results 37
Product News 38
Jun 21, 2017: Protea introduces new molecular imaging technology 38
Other Significant Developments 39
Jul 12, 2017: Protea Announces New Test Methods for Therapeutic Antibodies 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List Of Tables


Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Key Facts 2
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Protea Biosciences Group Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Protea Biosciences Group Inc, Medical Devices Deals, 2012 to YTD 2018 10
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Protea Biosciences Enters into Co-Marketing Agreement with Proteos 13
Protea Biosciences Enters into Agreement with Agilent Technologies 14
Protea Biosciences Enters Into Research Agreement With Virginia Commonwealth University For Molecular Imaging Techniques 15
Waters Enters Into Co-Marketing Agreement With Protea Biosciences Group For LASEI DP-1000 16
Protea Biosciences Group Enters Into Co-Development Agreement With Oak Ridge National Lab 17
Protea Biosciences Enters into License Agreement with George Washington University 18
Protea Biosciences Files Registration Statement to Raise up to USD17.3 Million in Public Offering of Shares 19
Protea Biosciences Group Raises USD0.6 Million in Private Placement 20
Protea Biosciences Raises USD0.98 Million in Public Offering of Units 21
Protea Biosciences Raises USD2.53 Million in Public Offering of Units 22
Protea Biosciences Group Completes Private Placement Of Shares For US$0.7 Million 23
Protea Biosciences Completes Private Placement Of Shares For US$0.5 Million 24
Protea Biosciences Raises USD0.1 Million in Private Placement of Debentures 25
Protea Biosciences Raises USD1.61 Million in Private Placement of Debentures 26
Protea Biosciences Raises USD2 Million in Private Placement of Debentures 27
Protea Biosciences Group Completes Private Placement Of Debt Securities For US$0.3 Million 28
Purdue University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 29
Princeton University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 30
Protea Biosciences to Acquire vivoPharm for USD11.2 Million 31
AzurRx BioPharma Acquires ProteaBio Europe for USD7 Million 33
Protea Biosciences Group Inc, Key Competitors 34
Protea Biosciences Group Inc, Key Employees 35
Protea Biosciences Group Inc, Subsidiaries 36

List Of Figures


Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Protea Biosciences Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Protea Biosciences Group Inc, Medical Devices Deals, 2012 to YTD 2018 10

Protea Biosciences Group Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research,

USD 250 View Report

Protea Biosciences Group Inc - Medical Equipment - Deals and Alliances Profile

Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research,

USD 250 View Report

Protea Biosciences Group Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research,

USD 250 View Report

Protea Biosciences Group Inc - Medical Equipment - Deals and Alliances Profile

Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research,

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available